Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues. - Wikidata - awgldk - TriplyDB

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

http://www.wikidata.org/entity/Q37231202

about

Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-mDM2 protein-protein interaction

P2860

Q35559055-53C21BDE-446D-46BA-BDA7-C999776E94E9 Q37286347-43D1DB3C-CE84-4E95-A95C-A449678F395A

P2860

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

http://www.wikidata.org/entity/Q37231202

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@en

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@nl

type

label

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@en

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@nl

prefLabel

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@en

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@nl

P1433

Q37231202-34C548BF-A8B3-42EF-9C65-97669FF99179

P1476

Q37231202-769C281B-E64C-4261-B6C8-F9B33669A597

P2093

Q37231202-11BD4393-CC84-4307-BF4D-43191276E7C9

Q37231202-79C47C7D-B879-4A16-9DD7-3F1EFC0268FA

Q37231202-A6DACEB5-E58E-4E0C-A9DB-920E37505F14

Q37231202-DB56FD07-5899-4139-A02B-BD8EB3A6581D

Q37231202-FE401D2A-A544-4351-AB69-CCAE5115A735

P2860

Q37231202-079F5259-FB30-45A8-A92B-2670892D663E

Q37231202-0C344AEB-B3DE-44FE-8BC2-EA257E502234

Q37231202-0DA8C138-B24B-4EA3-9ECF-34CB5220CEC4

Q37231202-18A86DAF-41B8-4D66-8B04-662A455D1779

Q37231202-1AC6A3BB-4D5D-4B37-9E5C-DD9D4AE0E3A2

Q37231202-385AFB78-B4CD-4CF2-9105-DC83A45B249A

Q37231202-46C9CA78-373B-463D-86AD-B3CEA2B79DF1

Q37231202-4AA1D836-5438-466E-8E25-6791286884DE

Q37231202-52CB8A25-24F9-47C0-B4CE-A1DBE63887A5

Q37231202-5E22CE07-E580-4DAC-A3F7-A9CB7EFBADE4

P304

Q37231202-1128A4BD-D8E9-4096-9959-0A996D7A8EBC

P31

Q37231202-AFB4F2CE-16A7-495C-A041-BC4139CE5ADC

P356

Q37231202-1173861C-D72D-4C7F-BB9D-41645B445451

P433

Q37231202-5044FB84-02A1-4AD2-88E0-199520AE4F4B

P478

Q37231202-6ACDF5E1-BE55-404D-867A-5D9B59297605

P577

Q37231202-412A35AF-0614-4990-A8A9-DDA4AF3ECCA7

P5875

Q37231202-323D2DC3-F6E3-4EB1-9346-54CD958A4BD8

P698

Q37231202-0A00F8CB-E288-4D23-9DAA-32ABA78F8880

P932

Q37231202-0401FD2B-B033-4780-959D-B344F18F7DF2

P356

J.TETLET.2009.01.081

P1433

Tetrahedron Letters

P1476

Evaluation of Chlorofusin, its Seven Chromophore Diastereomers, and Key Analogues.

@en

P2093

Dale L Boger

http://www.w3.org/2001/XMLSchema#string

Inkyu Hwang

http://www.w3.org/2001/XMLSchema#string

Mark Searcey

http://www.w3.org/2001/XMLSchema#string

Ryan C Clark

http://www.w3.org/2001/XMLSchema#string

Sang Yeul Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

Mdm2 promotes the rapid degradation of p53

Regulation of p53 stability by Mdm2

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Mapping of the p53 and mdm-2 interaction domains

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Rescuing the function of mutant p53.

A specific mechanism of nonspecific inhibition.

Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions.

MDM2 oncogene as a novel target for human cancer therapy.

P304

3151-3153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TETLET.2009.01.081

http://www.w3.org/2001/XMLSchema#string

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41453090

http://www.w3.org/2001/XMLSchema#string

P698

20161293

http://www.w3.org/2001/XMLSchema#string

P932

2697908

http://www.w3.org/2001/XMLSchema#string